VCM
AZN icon

Versant Capital Management’s AstraZeneca AZN Stock Holding History

Versant Capital Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.36M Buy
+7,263
New +$1.37M 0.12% 99
2026
Q1 		– Sell
-5,991
Closed -$1.1M – 2786
2025
Q4 		$1.1M Buy
5,991
+579
+11% +$102K 0.14% 85
2025
Q3 		$830K Buy
5,412
+878
+19% +$133K 0.11% 104
2025
Q2 		$634K Sell
4,534
-114
-2% -$16K 0.1% 130
2025
Q1 		$683K Buy
4,648
+4,281
+1,166% +$619K 0.11% 109
2024
Q4 		$48.1K Buy
367
+353
+2,521% +$49.4K 0.01% 593
2024
Q3 		$2.1K Sell
14
-218
-94% -$35.2K ﹤0.01% 1551
2024
Q2 		$36.1K Buy
232
+218
+1,557% +$32.8K 0.01% 502
2024
Q1 		$1.83K Hold
14
– – ﹤0.01% 1382
2023
Q4 		$1.82K Sell
14
-47
-77% -$6.11K ﹤0.01% 1317
2023
Q3 		$8.19K Buy
61
+3
+5% +$410 ﹤0.01% 799
2023
Q2 		$8.23K Hold
58
– – ﹤0.01% 848
2023
Q1 		$7.98K Buy
58
+47
+427% +$6.32K ﹤0.01% 782
2022
Q4 		$1.42K Hold
11
– – ﹤0.01% 1223
2022
Q3 		$1K Hold
11
– – ﹤0.01% 1184
2022
Q2 		$1K Hold
11
– – ﹤0.01% 1203
2022
Q1 		$1K Hold
11
– – ﹤0.01% 1231
2021
Q4 		$1K Sell
11
-2
-15% -$235 ﹤0.01% 1226
2021
Q3 		$2K Buy
+13
New +$1.51K ﹤0.01% 1098
2018
Q1 		– Sell
-283
Closed -$19K – 1482
2017
Q4 		$19K Buy
+283
New +$19.1K 0.01% 672

Other funds holding AZN

RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
AV
ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return
MIF
Mediolanum International Funds Dublin 1, Ireland $11.7B AUM 47.18% 1-Year Est. Return
ZIC
ZWJ Investment Counsel Atlanta, Georgia $3.09B AUM 39.43% 1-Year Est. Return
AIM
Achmea Investment Management Zeist, Netherlands $4B AUM 31.99% 1-Year Est. Return

Versant Capital Management's AZN Position: Q2 2026 in Review

Versant Capital Management opened a new position in AstraZeneca (AZN) in Q2 2026: 7,263 shares worth $1.36M. The stake represents 0.12% of the portfolio and ranks #99 among its holdings. This is a return to the name: Versant Capital Management previously reported a position in AZN as recently as Q4 2025.

Versant Capital Management first reported a position in AZN in Q4 2017 and has held it in 20 quarters since. 396 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Versant Capital Management held 7,263 shares of AstraZeneca worth $1.36M as of Q2 2026.
  • AstraZeneca was a new Versant Capital Management position in Q2 2026.
  • AstraZeneca made up 0.12% of Versant Capital Management's portfolio in Q2 2026, its #99 holding.
  • Versant Capital Management first reported a position in AstraZeneca in Q4 2017 and has held it in 20 quarters since.
  • 396 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.